Y-mAbs Therapeutics, Inc. Total Liabilities
Y-mAbs Therapeutics, Inc. had Total Liabilities of $29.72 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-08-08
- 2025-06-30: Liabilities $29.72M.
- 2025-03-31: Liabilities $23.16M.
- 2024-12-31: Liabilities $27.90M.
- 2024-09-30: Liabilities $28.49M.
| Period end | Liabilities |
|---|---|
| 2025-06-30 | $29.72M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $23.16M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $27.90M 10-Q · filed 2025-08-08 |
| 2024-09-30 | $28.49M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $48.70M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $24.13M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $26.88M 10-K · filed 2025-03-04 |
| 2023-09-30 | $28.73M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $27.71M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $29.62M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $32.23M 10-K · filed 2024-02-29 |
| 2022-09-30 | $36.02M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $33.78M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $33.58M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $32.68M 10-K · filed 2023-03-30 |
| 2021-09-30 | $29.13M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $25.16M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $22.70M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $26.21M 10-K · filed 2022-03-01 |
| 2020-09-30 | $26.68M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $21.32M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $18.74M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $17.46M 10-K · filed 2021-03-01 |
| 2019-09-30 | $17.75M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $17.66M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $14.48M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $11.40M 10-K · filed 2020-03-12 |
| 2018-09-30 | $11.37M 10-Q · filed 2018-11-13 |
| 2017-12-31 | $9.97M 10-K · filed 2019-03-22 |